TNDM Tandem Diabetes Care, Inc. logo

TNDM Tandem Diabetes Care, Inc.

Healthcare
$14.96-5.04%ClosedMarket Cap: $1.03B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

7.73

P/S

1.00

EV/EBITDA

-20.92

DCF Value

$-47.35

FCF Yield

-0.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

54.9%

Operating Margin

-7.9%

Net Margin

-9.2%

ROE

-68.3%

ROA

-8.2%

ROIC

-8.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$247.2M$-20.4M$
Q4 null$290.4M$-589.0K$
FY null$1.01B$-204.7M$
Q3 null$249.3M$-21.2M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$31.69

Target (Median)

$28.00

Target Range

$21.00 - $55.00

4 Strong Buy9 Buy12 Hold0 Sell0 Strong Sell
B of A SecuritiesNeutral
2026-05-18
BarclaysOverweight
2026-05-11
Truist SecuritiesBuy
2026-05-11
TD CowenBuy
2026-04-20
Goldman SachsNeutral
2026-04-09

Trading Activity

Insider Trades

View All
Malagueira Joao Paulo Falcaodirector
SellFri May 22
Malagueira Joao Paulo Falcaodirector
SellFri May 22
Howell Peyton Rdirector
SellFri May 22
Howell Peyton Rdirector
SellFri May 22
Beaver Sandradirector
SellFri May 22

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.64

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Peers